Quimioterapia antineoplásica no tratamento de linfoma de cães e gatos: revisão de literatura

Abstract

A literature review was conducted on the topic of "Antineoplastic Chemotherapy for Lymphomas in Dogs and Cats." Scientific articles from the last 10 years available on the PubMed digital platform were compiled and evaluated. This literature review aims to synthesize the most recent knowledge regarding chemotherapeutic approaches described in current veterinary literature, seeking to serve as a data source for researchers and veterinarians in scientific research and oncological clinical practice. Lymphoma is a common neoplasm in canine and feline clinics, and its standard treatment is antineoplastic chemotherapy, which achieves remission. The disease is not considered curable with the available therapeutic protocols. Data from scientific articles published in the last ten years of veterinary scientific research were collected. The review describes chemotherapeutic approaches for dogs and cats, evaluating pathophysiology, pharmacology, therapeutic methodology, adverse effects, and prognosis. The most relevant information was reported and summarized in an objective and consistent manner. The main goal of chemotherapy is not to cure, but to prolong the patient's survival and promote well-being. Much remains to be studied regarding canine and feline lymphoma, and the best treatment protocols for each specific type of lymphoma, leading to higher success rates and improved survival times.